pubmed-article:11602501 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11602501 | lifeskim:mentions | umls-concept:C0026266 | lld:lifeskim |
pubmed-article:11602501 | lifeskim:mentions | umls-concept:C1306235 | lld:lifeskim |
pubmed-article:11602501 | lifeskim:mentions | umls-concept:C0475224 | lld:lifeskim |
pubmed-article:11602501 | lifeskim:mentions | umls-concept:C0302350 | lld:lifeskim |
pubmed-article:11602501 | lifeskim:mentions | umls-concept:C0152060 | lld:lifeskim |
pubmed-article:11602501 | lifeskim:mentions | umls-concept:C0449445 | lld:lifeskim |
pubmed-article:11602501 | pubmed:issue | 16 | lld:pubmed |
pubmed-article:11602501 | pubmed:dateCreated | 2001-10-16 | lld:pubmed |
pubmed-article:11602501 | pubmed:abstractText | Mitral regurgitation (MR) conveys adverse prognosis in ischemic heart disease. Because such MR is related to increased leaflet tethering by displaced attachments to the papillary muscles (PMs), it is incompletely treated by annular reduction. We therefore addressed the hypothesis that such MR can be reduced by cutting a limited number of critically positioned chordae to the leaflet base that most restrict closure but are not required to prevent prolapse. This was tested in 8 mitral valves: a porcine in vitro pilot with PM displacement and 7 sheep with acute inferobasal infarcts studied in vivo with three-dimensional (3D) echo to quantify MR in relation to 3D valve geometry. | lld:pubmed |
pubmed-article:11602501 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11602501 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11602501 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11602501 | pubmed:language | eng | lld:pubmed |
pubmed-article:11602501 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11602501 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:11602501 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11602501 | pubmed:month | Oct | lld:pubmed |
pubmed-article:11602501 | pubmed:issn | 1524-4539 | lld:pubmed |
pubmed-article:11602501 | pubmed:author | pubmed-author:SullivanSS | lld:pubmed |
pubmed-article:11602501 | pubmed:author | pubmed-author:LevineR ARA | lld:pubmed |
pubmed-article:11602501 | pubmed:author | pubmed-author:YoganathanA... | lld:pubmed |
pubmed-article:11602501 | pubmed:author | pubmed-author:ChouC SCS | lld:pubmed |
pubmed-article:11602501 | pubmed:author | pubmed-author:ConradCC | lld:pubmed |
pubmed-article:11602501 | pubmed:author | pubmed-author:GuerreroJ LJL | lld:pubmed |
pubmed-article:11602501 | pubmed:author | pubmed-author:Handschumache... | lld:pubmed |
pubmed-article:11602501 | pubmed:author | pubmed-author:MessasEE | lld:pubmed |
pubmed-article:11602501 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:11602501 | pubmed:day | 16 | lld:pubmed |
pubmed-article:11602501 | pubmed:volume | 104 | lld:pubmed |
pubmed-article:11602501 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11602501 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11602501 | pubmed:pagination | 1958-63 | lld:pubmed |
pubmed-article:11602501 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:meshHeading | pubmed-meshheading:11602501... | lld:pubmed |
pubmed-article:11602501 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11602501 | pubmed:articleTitle | Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. | lld:pubmed |
pubmed-article:11602501 | pubmed:affiliation | Cardiac Ultrasound Laboratory and Surgical Cardiovascular Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. | lld:pubmed |
pubmed-article:11602501 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11602501 | pubmed:publicationType | In Vitro | lld:pubmed |
pubmed-article:11602501 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:11602501 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11602501 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11602501 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11602501 | lld:pubmed |